Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KRT8 antibody

This anti-KRT8 antibody is a Mouse Monoclonal antibody detecting KRT8 in WB, IHC, FACS, IHC (p) and IHC (fro). Suitable for Human.
Catalog No. ABIN2138820
-15% Promotion 2026
$1,343.08
$1,580.09
save $237.01 (-15 %)
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 9 to 11 Business Days

Quick Overview for KRT8 antibody (ABIN2138820)

Target

See all KRT8 Antibodies
KRT8 (Keratin 8 (KRT8))

Reactivity

  • 315
  • 90
  • 87
  • 67
  • 66
  • 64
  • 63
  • 16
  • 14
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human

Host

  • 168
  • 159
  • 3
Mouse

Clonality

  • 187
  • 140
  • 1
Monoclonal

Conjugate

  • 172
  • 26
  • 17
  • 8
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This KRT8 antibody is un-conjugated

Application

  • 233
  • 161
  • 130
  • 102
  • 73
  • 52
  • 47
  • 41
  • 41
  • 39
  • 35
  • 30
  • 23
  • 5
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone

M20
  • Immunogen

    Cytokeratin 8 antibody was raised in Mouse using keratin isolated from the human breast carcinoma cell line MCF-7 as the immunogen.

    Isotype

    IgG1
  • Application Notes

    FC: 1:100-1:200, IHC: 1:100-1:200, WB: 1:100-1:1000

    Restrictions

    For Research Use only
  • Concentration

    Lot specific

    Buffer

    In PBS containg 0.09 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C
  • Target

    KRT8 (Keratin 8 (KRT8))

    Alternative Name

    Cytokeratin 8
You are here:
Chat with us!